Health Services Research
Latest posts by Health Services Research (see all)
- Medication Nonadherence: The Role of Cost, Community, and Individual Factors - Aug. 25, 2016
- The Seven Pillars Response to Patient Safety Incidents: Effects on Medical Liability Processes… - Aug. 25, 2016
- Decreasing Malpractice Claims by Reducing Preventable Perinatal Harm - Aug. 23, 2016
- Improving Care Transitions Management: Examining the Role of Accountable Care Organization… - Aug. 23, 2016
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.